526 related articles for article (PubMed ID: 19282028)
1. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
2. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
3. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
Fu H; Björkman L; Janmey P; Karlsson A; Karlsson J; Movitz C; Dahlgren C
BMC Cell Biol; 2004 Dec; 5(1):50. PubMed ID: 15625007
[TBL] [Abstract][Full Text] [Related]
4. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
Forsman H; Dahlgren C
Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
[TBL] [Abstract][Full Text] [Related]
5. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.
Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
[TBL] [Abstract][Full Text] [Related]
7. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
8. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
[TBL] [Abstract][Full Text] [Related]
11. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
Matron C; Chakravarti A; Allaeys I; Poubelle PE
Free Radic Biol Med; 2010 Jan; 48(2):207-15. PubMed ID: 19854263
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response.
Liu L; Harbecke O; Elwing H; Follin P; Karlsson A; Dahlgren C
J Immunol; 1998 Mar; 160(5):2463-8. PubMed ID: 9498791
[TBL] [Abstract][Full Text] [Related]
13. The anionic amphiphile SDS is an antagonist for the human neutrophil formyl peptide receptor 1.
Thorén FB; Karlsson J; Dahlgren C; Forsman H
Biochem Pharmacol; 2010 Aug; 80(3):389-95. PubMed ID: 20394736
[TBL] [Abstract][Full Text] [Related]
14. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
[TBL] [Abstract][Full Text] [Related]
15. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
16. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
[TBL] [Abstract][Full Text] [Related]
17. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
Kretschmer D; Rautenberg M; Linke D; Peschel A
J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
[TBL] [Abstract][Full Text] [Related]
18. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
19. Capacitative Ca2+ influx and activation of the neutrophil respiratory burst. Different regulation of plasma membrane- and granule-localized NADPH-oxidase.
Granfeldt D; Samuelsson M; Karlsson A
J Leukoc Biol; 2002 Apr; 71(4):611-7. PubMed ID: 11927647
[TBL] [Abstract][Full Text] [Related]
20. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C
J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
